Transforming antibody discovery, Transforming medicine

iBody accelerates the development of next-generation therapeutics and diagnostics by delivering high-performance monoclonal antibodies that meet challenging research and development needs.
Our proprietary antibody discovery platform enables rapid identification of antibodies against difficult targets, helping customers reduce development time, overcome technical barriers, and improve R&D success.
With patented technology in Japan, the United States, and Europe, iBody partners with pharmaceutical and diagnostic companies worldwide through contract research, strategic collaborations, and technology licensing.